Potential Oral Anticancer Therapeutic Agents of Hexahydrocurcumin-Encapsulated Chitosan Nanoparticles against MDA-MB-231 Breast Cancer Cells

Potential Oral Anticancer Therapeutic Agents of Hexahydrocurcumin-Encapsulated Chitosan Nanoparticles against MDA-MB-231 Breast Cancer Cells

Hexahydrocurcumin-encapsulated chitosan nanoparticles (HHC-CS-NPs) were formulated by oil-in-water emulsification and ionotropic gelation and optimized using the Box–Behnken design. The particle size, zeta potential, and encapsulation efficiency of the optimized HHC-CS-NPs were 256 ± 14 nm, 27.3 ± 0...

Full description

Bibliographic Details
Main Authors: Feuangthit N. Sorasitthiyanukarn, Chawanphat Muangnoi, Clinton B. Gomez, Apichart Suksamrarn, Pranee Rojsitthisak, Pornchai Rojsitthisak
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Pharmaceutics
Subjects:
hexahydrocurcumin
chitosan nanoparticles
Box–Behnken design
anticancer
Online Access:https://www.mdpi.com/1999-4923/15/2/472

Internet

https://www.mdpi.com/1999-4923/15/2/472

Similar Items